WO2002000825A3 - A novel polypeptide, a nuclear receptor protein stromal antigene 110.34 and the polynucleotide encoding the polypeptide - Google Patents

A novel polypeptide, a nuclear receptor protein stromal antigene 110.34 and the polynucleotide encoding the polypeptide Download PDF

Info

Publication number
WO2002000825A3
WO2002000825A3 PCT/CN2001/000941 CN0100941W WO0200825A3 WO 2002000825 A3 WO2002000825 A3 WO 2002000825A3 CN 0100941 W CN0100941 W CN 0100941W WO 0200825 A3 WO0200825 A3 WO 0200825A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptide
antigene
polynucleotide encoding
receptor protein
nuclear receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2001/000941
Other languages
French (fr)
Chinese (zh)
Other versions
WO2002000825A2 (en
Inventor
Yumin Mao
Yi Xie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Biowindow Gene Development Inc
Original Assignee
Shanghai Biowindow Gene Development Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Biowindow Gene Development Inc filed Critical Shanghai Biowindow Gene Development Inc
Priority to AU93610/01A priority Critical patent/AU9361001A/en
Publication of WO2002000825A2 publication Critical patent/WO2002000825A2/en
Publication of WO2002000825A3 publication Critical patent/WO2002000825A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention discloses a novel polypeptide, a nuclear receptor protein stromal antigene 110.34, the polynucleotide encoding the polypeptide and the method for producing the polypeptide by DNA recombinant technology. The invention also discloses the uses of the polypeptide in methods for treating various diseases, such as malignant tumor, hemopathy, development disorders, immunological disease, and various inflammation, etc. The invention also discloses the agonists against the polypeptide and the therapeutic action thereof. The invention also discloses the uses of the polynucleotide encoding the novel nuclear receptor protein stromal antigene 110.34.
PCT/CN2001/000941 2000-06-12 2001-06-11 A novel polypeptide, a nuclear receptor protein stromal antigene 110.34 and the polynucleotide encoding the polypeptide Ceased WO2002000825A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU93610/01A AU9361001A (en) 2000-06-12 2001-06-11 A novel polypeptide, a nuclear receptor protein stromal antigene 110.34 and the polynucleotide encoding the polypeptide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN00116420.1 2000-06-12
CN00116420A CN1327987A (en) 2000-06-12 2000-06-12 Polypeptide-nclein matrix antigen 110.34 and polynucleotide for coding it

Publications (2)

Publication Number Publication Date
WO2002000825A2 WO2002000825A2 (en) 2002-01-03
WO2002000825A3 true WO2002000825A3 (en) 2002-05-02

Family

ID=4585824

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000941 Ceased WO2002000825A2 (en) 2000-06-12 2001-06-11 A novel polypeptide, a nuclear receptor protein stromal antigene 110.34 and the polynucleotide encoding the polypeptide

Country Status (3)

Country Link
CN (1) CN1327987A (en)
AU (1) AU9361001A (en)
WO (1) WO2002000825A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316910A (en) * 1991-03-19 1994-05-31 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Bioassay for influenza A and B nucleoprotein

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316910A (en) * 1991-03-19 1994-05-31 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Bioassay for influenza A and B nucleoprotein

Also Published As

Publication number Publication date
AU9361001A (en) 2002-01-08
WO2002000825A2 (en) 2002-01-03
CN1327987A (en) 2001-12-26

Similar Documents

Publication Publication Date Title
WO2001083688A3 (en) A novel polypeptide, a human subunit 13 phosphatidylinositol-4-phosphate-5-kinase ii beta and the polynucleotide encoding the polypeptide
WO2002000825A3 (en) A novel polypeptide, a nuclear receptor protein stromal antigene 110.34 and the polynucleotide encoding the polypeptide
WO2002000822A3 (en) A NOVEL POLYPEPTIDE, A HUMAIN PROTEIN SYNTHESIS INITIATION FACTOR SUB-UNIT 2 β 16.5 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE
WO2002000826A3 (en) A novel polypeptide, a human dna methylation protein and the polynucleotide encoding the polypeptide
WO2001096525A3 (en) A novel polypeptide, a pogo conversion unit 18 and the polynucleotide encoding the polypeptide
WO2001075023A3 (en) A novel polypeptide, human phosphatidylinositol-3 (ptdins 3) kinase 9 and the polynucleotide encoding the polypeptide
WO2001079439A3 (en) A novel polypeptide, a human cannabinoid receptor protein 19 and the polynucleotide encoding the polypeptide
WO2001075054A3 (en) A novel polypeptide, microglobulin transcription human regulation factor 30 and the polynucleotide encoding the polypeptide
WO2001075025A3 (en) A novel polypeptide, human thyroglobuline 9 and the polynuceotide encoding the polypeptide
WO2001075053A3 (en) A novel polypeptide, human chaperonine 14 and the polynucleotide encoding the polypeptide
WO2001081536A3 (en) A novel polypeptide, a human ysk1 kinase protein 10, and the polynucleotide encoding the polypeptide
WO2002000824A3 (en) A NOVEL POLYPEPTIDE, A HUMAN tre ONCOGENE 10.56 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE
WO2001075014A3 (en) A novel polypeptide, human phosphatidylinositol-3 (ptdins 3) kinase 35 and the polynucleotide encoding the polypeptide
WO2001083685A3 (en) A novel polypeptide, a cap protein 10 and the polynucleotide encoding the polypeptide
WO2001075029A3 (en) A novel polypeptide, nf-e2-associated human factor 11 and the polynucleotide encoding the polypeptide
WO2002008421A1 (en) A novel polypeptide, a human tumor necrosis factor receptor 21.45 and the polynucleotide encoding the polypeptide
WO2001075036A3 (en) A novel polypeptide, human immunophiline 14 and the polynucleotide encoding the polypeptide
WO2001075024A3 (en) A novel polypeptide, nf-e2-associated human factor 13 and the polynucleotide encoding the polypeptide
WO2001075011A3 (en) A novel polypeptide, cytochrome human constitution protein 10 and the polynucleotide encoding the polypeptide
WO2001075062A3 (en) A novel polypeptide, human hydrogenase 10 and the polynucleotide encoding the polypeptide
WO2001081537A3 (en) A NOVEL POLYPEPTIDE, DNA REPLICATION FACTOR C(A1) 37Kd HUMAN SUB-UNIT 49, AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE
WO2001075010A3 (en) A novel polypeptide, human nuclear transduction protein 25 containing a structural atp/gtp domain
WO2002000827A3 (en) A novel polypeptide, a dna-cysteine methyltransferase methylation protein 10 and the polynucleotide encoding the polypeptide
WO2001075043A3 (en) A novel polypeptide, dna-dependent human protein kinase 9 and the polynucleotide encoding the polypeptide
WO2001083684A3 (en) A novel polypeptide, a human zinc-finger krab kraz2-13 protein and the polynucleotide encoding the polypeptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP